Engineers Gate Manager’s Aurinia Pharmaceuticals AUPH Stock Holding History

Engineers Gate Manager’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$674K	Sell	39,716 -53,499	-57%	-$855K	0.01%	1319
2026 Q1	$1.38M	Sell	93,215 -24,268	-21%	-$355K	0.02%	889
2025 Q4	$1.87M	Buy	117,483 +61,678	+111%	+$874K	0.02%	739
2025 Q3	$617K	Buy	55,805 +36,621	+191%	+$400K	0.01%	1427
2025 Q2	$162K	Buy	+19,184	New	+$154K	﹤0.01%	1930
2024 Q4	–	Sell	-10,520	Closed	-$77.1K	–	2216
2024 Q3	$77.1K	Buy	+10,520	New	+$65.2K	﹤0.01%	1949
2024 Q1	–	Sell	-22,898	Closed	-$206K	–	1908
2023 Q4	$206K	Sell	22,898 -18,711	-45%	-$154K	0.01%	1629
2023 Q3	$323K	Buy	41,609 +24,840	+148%	+$243K	0.01%	1282
2023 Q2	$162K	Buy	+16,769	New	+$174K	0.01%	1507
2022 Q3	–	Sell	-25,187	Closed	-$253K	–	1612
2022 Q2	$253K	Buy	+25,187	New	+$282K	0.01%	1517
2022 Q1	–	Sell	-18,689	Closed	-$427K	–	1845
2021 Q4	$427K	Buy	+18,689	New	+$443K	0.02%	1170

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's AUPH Position: Q2 2026 in Review

Engineers Gate Manager reduced its Aurinia Pharmaceuticals (AUPH) stake by 57% in Q2 2026, selling an estimated $855K and leaving 39,716 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #1319.

Engineers Gate Manager first reported a position in AUPH in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.87M in Q4 2025. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Engineers Gate Manager held 39,716 shares of Aurinia Pharmaceuticals worth $674K as of Q2 2026.
Engineers Gate Manager sold 53,499 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $855K.
Aurinia Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1319 holding.
Engineers Gate Manager first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
Engineers Gate Manager's Aurinia Pharmaceuticals position peaked at $1.87M in Q4 2025.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.